WIPRO NEUROSAFE Trademark

Trademark Overview

On Monday, September 12, 2022, a trademark application was filed for WIPRO NEUROSAFE with the United States Patent and Trademark Office. The USPTO has given the WIPRO NEUROSAFE trademark a serial number of 97586919. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Friday, November 3, 2023. This trademark is owned by Wipro Limited. The WIPRO NEUROSAFE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Software as a service (SAAS) services featuring software for use in assessing and improving operational excellence associated with vaccine safety
wipro neurosafe

General Information

Serial Number97586919
Word MarkWIPRO NEUROSAFE
Filing DateMonday, September 12, 2022
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateFriday, November 3, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and ServicesSoftware as a service (SAAS) services featuring software for use in assessing and improving operational excellence associated with vaccine safety

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 27, 2022
Primary Code042
First Use Anywhere DateSaturday, July 15, 2023
First Use In Commerce DateSaturday, July 15, 2023

Trademark Owner History

Party NameWipro Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBangalore 560035
IN
Party NameWipro Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBangalore 560035
IN

Trademark Events

Event DateEvent Description
Thursday, February 1, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 3, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, November 3, 2023NON-FINAL ACTION E-MAILED
Friday, November 3, 2023SU - NON-FINAL ACTION - WRITTEN
Friday, September 22, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, September 18, 2023USE AMENDMENT FILED
Friday, September 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, September 18, 2023TEAS STATEMENT OF USE RECEIVED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 13, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 11, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, March 10, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, March 10, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, October 17, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, October 17, 2022NON-FINAL ACTION E-MAILED
Monday, October 17, 2022NON-FINAL ACTION WRITTEN
Thursday, October 13, 2022ASSIGNED TO EXAMINER
Tuesday, September 27, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 15, 2022NEW APPLICATION ENTERED

Related Keywords

neurosafe wipro software excellence associated vaccine safety operational assessing service saas services